Clinical Trials Related to Myelodysplastic Syndromes

Related studies linked through entity extraction aliases.

A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome

Status: UNKNOWN
Phase: N/A

Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015

Status: COMPLETED
Phase: NA

A Study of RO6870810/TEN-010 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndrome

Status: COMPLETED
Phase: PHASE1

Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT

Status: COMPLETED
Phase: PHASE2

Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes

Status: COMPLETED
Phase: PHASE2

Study of TCP-ATRA for Adult Patients With AML and MDS

Status: COMPLETED
Phase: PHASE1

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Status: RECRUITING
Phase: N/A

Extension Study to Evaluate Long-Term Effects of Luspatercept in Patients With Myelodysplastic Syndromes (MDS) (A536-05/MK-6143-003)

Status: COMPLETED
Phase: PHASE2

A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)

Status: TERMINATED
Phase: PHASE1

Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes

Status: TERMINATED
Phase: PHASE2

Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes

Status: COMPLETED
Phase: PHASE2

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Status: COMPLETED
Phase: PHASE1

Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors

Status: COMPLETED
Phase: PHASE1

Volasertib in Combination With Azacitidine in Japanese Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Status: COMPLETED
Phase: PHASE1

Intra-Osseous Co-Transplant of UCB and hMSC

Status: COMPLETED
Phase: EARLY_PHASE1

Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies

Status: COMPLETED
Phase: N/A

A Study of Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS)

Status: COMPLETED
Phase: PHASE4

Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Status: COMPLETED
Phase: EARLY_PHASE1

Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms

Status: COMPLETED
Phase: PHASE2

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

Status: RECRUITING
Phase: PHASE1